OR5L2
gene geneOn this page
Also known as HTPCRX16HSHTPCRX16
Summary
OR5L2 (olfactory receptor family 5 subfamily L member 2, HGNC:8351) is a protein-coding gene on chromosome 11q12.1, encoding Olfactory receptor 5L2 (Q8NGL0). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26338 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 56 total
- MANE Select transcript:
NM_001004739
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8351 |
| Approved symbol | OR5L2 |
| Name | olfactory receptor family 5 subfamily L member 2 |
| Location | 11q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HTPCRX16, HSHTPCRX16 |
| Ensembl gene | ENSG00000205030 |
| Ensembl biotype | protein_coding |
| Entrez | 26338 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000378397
RefSeq mRNA: 1 — MANE Select: NM_001004739
NM_001004739
CCDS: CCDS31511
Canonical transcript exons
ENST00000378397 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001791207 | 55827219 | 55828154 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 57.36.
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| upper leg skin | UBERON:0004262 | 57.36 | silver quality |
| amniotic fluid | UBERON:0000173 | 48.98 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| granulocyte | CL:0000094 | 41.07 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 39.95 | gold quality |
| skin of hip | UBERON:0001554 | 39.86 | silver quality |
| deltoid | UBERON:0001476 | 39.83 | gold quality |
| saphenous vein | UBERON:0007318 | 39.83 | gold quality |
| parotid gland | UBERON:0001831 | 39.81 | gold quality |
| oocyte | CL:0000023 | 39.80 | gold quality |
| urethra | UBERON:0000057 | 39.80 | gold quality |
| heart right ventricle | UBERON:0002080 | 39.79 | gold quality |
| pericardium | UBERON:0002407 | 39.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.15 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or5l14 | ENSMUSG00000075143 |
| mus_musculus | Or5l13 | ENSMUSG00000075144 |
| rattus_norvegicus | ENSRNOG00000080593 | |
| rattus_norvegicus | Or5l14b | ENSRNOG00000082542 |
| rattus_norvegicus | Or5l13 | ENSRNOG00000091137 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761)
Protein
Protein identifiers
Olfactory receptor 5L2 — Q8NGL0 (reviewed: Q8NGL0)
Alternative names: HTPCRX16, Olfactory receptor OR11-153
All UniProt accessions (1): Q8NGL0
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004739* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (21 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence variant 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGL0-F1 | 89.60 | 0.68 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (2): 5, 195
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 25 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GSE15659_TREG_VS_TCONV_UP, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION
GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), signal transduction (GO:0007165), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
344 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR5L2 | KRTAP19-8 | Q3LI54 | 581 |
| OR5L2 | AKAP3 | O75969 | 518 |
| OR5L2 | KRTAP10-1 | P60331 | 506 |
| OR5L2 | FRMPD3 | Q5JV73 | 435 |
| OR5L2 | KNOP1 | Q1ED39 | 417 |
| OR5L2 | TRIM48 | Q8IWZ4 | 395 |
| OR5L2 | PRKACA | P17612 | 388 |
| OR5L2 | PRKACB | P22694 | 388 |
| OR5L2 | PRKACG | P22612 | 388 |
| OR5L2 | TRIM51 | Q9BSJ1 | 371 |
| OR5L2 | GPATCH4 | Q5T3I0 | 368 |
| OR5L2 | RPUSD3 | Q6P087 | 348 |
| OR5L2 | TAAR8 | Q969N4 | 338 |
| OR5L2 | MRM1 | Q6IN84 | 337 |
| OR5L2 | OTOG | Q6ZRI0 | 335 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A2R8YED5, A6ND48, B2RN74, O60412, O76099, O76100, O95047, P23271, P23272, P34982, P37069, P37072, P47884, P47890, P58170, Q15622, Q60879, Q8NG84, Q8NG94, Q8NG95, Q8NG98, Q8NG99, Q8NGA0, Q8NGA2, Q8NGE0, Q8NGG1, Q8NGL0, Q8NGP2, Q8NGS2, Q8NGW1, Q8NGZ2, Q8NGZ5, Q8NH06, Q8NH07, Q8NH80, Q8NHA4, Q8NHC7, Q8VEY3, Q8VFC9, Q8WZA6
Diamond homologs: A0A2R8YED5, O14581, O43749, O76099, O95221, P0C626, P0C7N1, P0C7N5, P0DN81, P23266, P23275, P30955, P47890, P58173, P58181, P59922, Q15617, Q15619, Q15622, Q60878, Q60881, Q60895, Q6IEU7, Q6UXT6, Q7TQQ0, Q7Z3T1, Q8N0Y5, Q8N146, Q8N162, Q8N628, Q8NG98, Q8NGA1, Q8NGC2, Q8NGE5, Q8NGF4, Q8NGF8, Q8NGG0, Q8NGG3, Q8NGG4, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
56 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
178 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:55827535:C:G | acceptor_gain | 0.8600 |
| 11:55827537:T:G | acceptor_gain | 0.8400 |
| 11:55827534:A:AG | acceptor_gain | 0.8300 |
| 11:55827621:ACCAT:A | donor_gain | 0.7700 |
| 11:55827539:T:TA | acceptor_gain | 0.7500 |
| 11:55827674:G:GT | donor_gain | 0.7200 |
| 11:55827774:A:G | acceptor_gain | 0.7200 |
| 11:55827921:C:T | donor_gain | 0.7100 |
| 11:55827536:ATGT:A | acceptor_gain | 0.7000 |
| 11:55827364:TTCAG:T | donor_loss | 0.6900 |
| 11:55827365:TCAGG:T | donor_loss | 0.6900 |
| 11:55827366:CAGGT:C | donor_loss | 0.6900 |
| 11:55827367:AGGTC:A | donor_loss | 0.6900 |
| 11:55827368:GGTCA:G | donor_loss | 0.6900 |
| 11:55827369:GTCAG:G | donor_loss | 0.6900 |
| 11:55827370:T:G | donor_loss | 0.6900 |
| 11:55827485:CAAAG:C | acceptor_gain | 0.6600 |
| 11:55827534:ACAT:A | acceptor_gain | 0.6600 |
| 11:55827487:AAGCC:A | acceptor_gain | 0.6400 |
| 11:55827488:AGCCA:A | acceptor_gain | 0.6400 |
| 11:55827536:ATGTG:A | acceptor_gain | 0.6400 |
| 11:55827285:T:G | donor_gain | 0.6300 |
| 11:55827681:T:A | donor_gain | 0.6300 |
| 11:55827900:A:G | donor_gain | 0.6300 |
| 11:55827479:CAAGG:C | acceptor_gain | 0.6200 |
| 11:55827480:AAGGA:A | acceptor_gain | 0.6200 |
| 11:55827481:AGGAC:A | acceptor_gain | 0.6200 |
| 11:55827486:AAAGC:A | acceptor_gain | 0.6200 |
| 11:55827674:G:T | donor_gain | 0.6200 |
| 11:55827371:CAG:C | donor_loss | 0.5800 |
AlphaMissense
2030 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:55827252:T:C | F12L | 0.834 |
| 11:55827254:C:A | F12L | 0.834 |
| 11:55827254:C:G | F12L | 0.834 |
| 11:55827747:T:C | F177L | 0.738 |
| 11:55827749:C:A | F177L | 0.738 |
| 11:55827749:C:G | F177L | 0.738 |
| 11:55827585:T:C | F123L | 0.695 |
| 11:55827587:T:A | F123L | 0.695 |
| 11:55827587:T:G | F123L | 0.695 |
| 11:55827930:T:C | F238L | 0.694 |
| 11:55827932:C:A | F238L | 0.694 |
| 11:55827932:C:G | F238L | 0.694 |
| 11:55827528:T:C | F104L | 0.673 |
| 11:55827530:T:A | F104L | 0.673 |
| 11:55827530:T:G | F104L | 0.673 |
| 11:55827309:T:C | F31L | 0.664 |
| 11:55827311:C:A | F31L | 0.664 |
| 11:55827311:C:G | F31L | 0.664 |
| 11:55827750:T:C | F178L | 0.662 |
| 11:55827752:C:A | F178L | 0.662 |
| 11:55827752:C:G | F178L | 0.662 |
| 11:55827519:T:C | F101L | 0.606 |
| 11:55827521:C:A | F101L | 0.606 |
| 11:55827521:C:G | F101L | 0.606 |
| 11:55827555:T:C | F113L | 0.573 |
| 11:55827557:C:A | F113L | 0.573 |
| 11:55827557:C:G | F113L | 0.573 |
| 11:55828089:A:C | S291R | 0.570 |
| 11:55828091:C:A | S291R | 0.570 |
| 11:55828091:C:G | S291R | 0.570 |
dbSNP variants (sampled 300 via entrez): RS1000012435 (11:55826221 A>G), RS1000085459 (11:55826032 A>G), RS1000726862 (11:55827189 T>C), RS1000778154 (11:55827367 A>G,T), RS1003376437 (11:55828393 CATT>C), RS1003489721 (11:55828226 T>A,C), RS1003560520 (11:55825732 A>T), RS1004058710 (11:55826005 T>C), RS1005515552 (11:55825548 C>A,G), RS1005627067 (11:55827971 C>G,T), RS1008212829 (11:55828650 T>C), RS1008826953 (11:55826624 T>C), RS1009486882 (11:55826027 G>A), RS1010125611 (11:55826632 A>G,T), RS1010272372 (11:55825804 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008839_600 | Height | 2.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.